K2
1 known investors
K2 Therapeutics is a biotech company that identifies innovative drug assets and develops them into medicines using a hub-and-spoke model with cross-regional clinical trials. Its pipeline focuses on first- and best-in-class cell therapies for solid tumors, including a PRAME-targeting therapy for cutaneous melanoma and synovial sarcoma.
Investors · 1
Frequently asked questions
- What does K2 do?
- K2 Therapeutics is a biotech company that identifies innovative drug assets and develops them into medicines using a hub-and-spoke model with cross-regional clinical trials. Its pipeline focuses on first- and best-in-class cell therapies for solid tumors, including a PRAME-targeting therapy for cutaneous melanoma and synovial sarcoma.
- Who are K2's investors?
- K2's investors include MPM BioImpact.